These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 36872867)

  • 1. Single-cell profiling of ineffective erythropoiesis in a mouse model of β-thalassaemia intermedia.
    Peng Y; Liang L; Zhang H; Liu H; Zhang G; Sun S; Guo X; Wang Y; Hu B; Liu R; Li Y; Nie L; Zhang J; Ye M; Ginzburg YZ; Lin Z; Yin B; Chen H; Liu J
    Br J Haematol; 2023 Jun; 201(5):982-994. PubMed ID: 36872867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ineffective erythropoiesis in beta-thalassemia is characterized by increased iron absorption mediated by down-regulation of hepcidin and up-regulation of ferroportin.
    Gardenghi S; Marongiu MF; Ramos P; Guy E; Breda L; Chadburn A; Liu Y; Amariglio N; Rechavi G; Rachmilewitz EA; Breuer W; Cabantchik ZI; Wrighting DM; Andrews NC; de Sousa M; Giardina PJ; Grady RW; Rivella S
    Blood; 2007 Jun; 109(11):5027-35. PubMed ID: 17299088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepcidin independent iron recycling in a mouse model of β-thalassaemia intermedia.
    Frazer DM; Wilkins SJ; Mirciov CS; Dunn LA; Anderson GJ
    Br J Haematol; 2016 Oct; 175(2):308-317. PubMed ID: 27410488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SLN124, a GalNac-siRNA targeting transmembrane serine protease 6, in combination with deferiprone therapy reduces ineffective erythropoiesis and hepatic iron-overload in a mouse model of β-thalassaemia.
    Vadolas J; Ng GZ; Kysenius K; Crouch PJ; Dames S; Eisermann M; Nualkaew T; Vilcassim S; Schaeper U; Grigoriadis G
    Br J Haematol; 2021 Jul; 194(1):200-210. PubMed ID: 33942901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased autophagy leads to decreased apoptosis during β-thalassaemic mouse and patient erythropoiesis.
    Chaichompoo P; Nithipongvanitch R; Kheansaard W; Tubsuwan A; Srinoun K; Vadolas J; Fucharoen S; Smith DR; Winichagoon P; Svasti S
    Sci Rep; 2022 Nov; 12(1):18628. PubMed ID: 36329049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. mRNA expression of iron regulatory genes in beta-thalassemia intermedia and beta-thalassemia major mouse models.
    Weizer-Stern O; Adamsky K; Amariglio N; Rachmilewitz E; Breda L; Rivella S; Rechavi G
    Am J Hematol; 2006 Jul; 81(7):479-83. PubMed ID: 16755567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exogenous iron increases hemoglobin in beta-thalassemic mice.
    Ginzburg YZ; Rybicki AC; Suzuka SM; Hall CB; Breuer W; Cabantchik ZI; Bouhassira EE; Fabry ME; Nagel RL
    Exp Hematol; 2009 Feb; 37(2):172-83. PubMed ID: 19059700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitoxantrone ameliorates ineffective erythropoiesis in a β-thalassemia intermedia mouse model.
    Zhang H; Liu R; Fang Z; Nie L; Ma Y; Sun F; Mei J; Song Z; Ginzburg YZ; Liu J; Chen H
    Blood Adv; 2024 Aug; 8(15):4017-4024. PubMed ID: 38861356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. β-thalassemia: a model for elucidating the dynamic regulation of ineffective erythropoiesis and iron metabolism.
    Ginzburg Y; Rivella S
    Blood; 2011 Oct; 118(16):4321-30. PubMed ID: 21768301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of heme oxygenase ameliorates anemia and reduces iron overload in a β-thalassemia mouse model.
    Garcia-Santos D; Hamdi A; Saxova Z; Fillebeen C; Pantopoulos K; Horvathova M; Ponka P
    Blood; 2018 Jan; 131(2):236-246. PubMed ID: 29180398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ineffective Erythropoiesis in β-Thalassaemia: Key Steps and Therapeutic Options by Drugs.
    Longo F; Piolatto A; Ferrero GB; Piga A
    Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. betaMinor-globin messenger RNA accumulation in reticulocytes governs improved erythropoiesis in beta thalassemic mice after erythropoietin complementary DNA electrotransfer in muscles.
    Samakoglu S; Fattori E; Lamartina S; Toniatti C; Stockholm D; Heard JM; Bohl D
    Blood; 2001 Apr; 97(8):2213-20. PubMed ID: 11290581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Number and maturation of reticulocytes in various genotypes of thalassaemia as assessed by flow cytometry.
    Khuhapinant A; Bunyaratvej A; Tatsumi N; Pribwai M; Fucharoen S
    Acta Haematol; 1994; 91(3):119-25. PubMed ID: 8091932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iron metabolism under conditions of ineffective erythropoiesis in β-thalassemia.
    Rivella S
    Blood; 2019 Jan; 133(1):51-58. PubMed ID: 30401707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deletion of TMPRSS6 attenuates the phenotype in a mouse model of β-thalassemia.
    Nai A; Pagani A; Mandelli G; Lidonnici MR; Silvestri L; Ferrari G; Camaschella C
    Blood; 2012 May; 119(21):5021-9. PubMed ID: 22490684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral ferroportin inhibitor ameliorates ineffective erythropoiesis in a model of β-thalassemia.
    Manolova V; Nyffenegger N; Flace A; Altermatt P; Varol A; Doucerain C; Sundstrom H; Dürrenberger F
    J Clin Invest; 2019 Dec; 130(1):491-506. PubMed ID: 31638596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HSP70 sequestration by free α-globin promotes ineffective erythropoiesis in β-thalassaemia.
    Arlet JB; Ribeil JA; Guillem F; Negre O; Hazoume A; Marcion G; Beuzard Y; Dussiot M; Moura IC; Demarest S; de Beauchêne IC; Belaid-Choucair Z; Sevin M; Maciel TT; Auclair C; Leboulch P; Chretien S; Tchertanov L; Baudin-Creuza V; Seigneuric R; Fontenay M; Garrido C; Hermine O; Courtois G
    Nature; 2014 Oct; 514(7521):242-6. PubMed ID: 25156257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iron metabolism and ineffective erythropoiesis in beta-thalassemia mouse models.
    Ramos P; Melchiori L; Gardenghi S; Van-Roijen N; Grady RW; Ginzburg Y; Rivella S
    Ann N Y Acad Sci; 2010 Aug; 1202():24-30. PubMed ID: 20712768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correcting β-thalassemia by combined therapies that restrict iron and modulate erythropoietin activity.
    Casu C; Pettinato M; Liu A; Aghajan M; Lo Presti V; Lidonnici MR; Munoz KA; O'Hara E; Olivari V; Di Modica SM; Booten S; Guo S; Neil G; Miari R; Shapir N; Zafir-Lavie I; Domev H; Ferrari G; Sitara D; Nai A; Rivella S
    Blood; 2020 Oct; 136(17):1968-1979. PubMed ID: 32556142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Interplay Between Peroxiredoxin-2 and Nuclear Factor-Erythroid 2 Is Important in Limiting Oxidative Mediated Dysfunction in β-Thalassemic Erythropoiesis.
    Matte A; De Falco L; Iolascon A; Mohandas N; An X; Siciliano A; Leboeuf C; Janin A; Bruno M; Choi SY; Kim DW; De Franceschi L
    Antioxid Redox Signal; 2015 Dec; 23(16):1284-97. PubMed ID: 26058667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.